[I-125] BQ3020, A POTENT ET(B)-SELECTIVE AGONIST, DISPLAYS SPECIES-DIFFERENCES IN ITS BINDING CHARACTARISTICS

被引:8
|
作者
NAMBI, P
PULLEN, M
机构
[1] Department of Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia
关键词
D O I
10.1016/0143-4179(95)90115-9
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Binding of [I-125]-BQ3020 to membranes prepared from rat cerebellum, dog lung and CHO cells stably transfected with the human endothelin ET(B) receptor clone was specific, saturable and of high affinity. The apparent dissociation constants (K(d)s) were 63, 53 and 112 pM for rat cerebellum, dog lung and human ET(B), respectively. The maximum bindings (B-max) were 3.8, 0.430 and 20 pmol/mg protein for rat cerebellum, dog lung and human clone, respectively. Competition binding experiments using [I-125]-BQ3020 and unlabelled ET-1, ET-3, S6c and BQ123 indicated that ET-1, ET-3 and S6c competed for [I-125]-B03020 binding with similar high affinity (IC50 similar to 0.3 nM), whereas BQ123 was ineffective in competing for [I-125]-BQ3020 binding. Time course experiments suggested that the binding of [I-125]-BQ3020 to all three preparations was rapid, and reached steady-state by similar to 40 min at 30 degrees C. Addition of excess unlabelled ET-1 resulted in partial dissociation (25-40%) from human ET(B) and dog lung receptors, whereas from rat cerebellum it was essentially irreversible. These data suggest that [I-125]-BQ3020 is a potent and selective ET(B) agonist and its reversible binding property is species-dependent.
引用
收藏
页码:191 / 196
页数:6
相关论文
共 11 条
  • [1] CHARACTERIZATION OF [I-125] ENDOTHELIN-1 AND [I-125] BQ3020 BINDING TO RAT CEREBELLAR ET(B) RECEPTORS
    KIRK, CNP
    WIDDOWSON, PS
    BRITISH JOURNAL OF PHARMACOLOGY, 1995, 116 : P193 - P193
  • [2] PHARMACOLOGICAL CHARACTERIZATION OF THE RAT CEREBELLAR ENDOTHELIN(B) (ET(B)) RECEPTOR USING THE NOVEL AGONIST RADIOLIGAND [I-125] BQ3020
    JARVIS, MF
    ASSAL, AA
    GESSNER, G
    BRAIN RESEARCH, 1994, 665 (01) : 33 - 38
  • [3] Characterization of [I-125]-endothelin-1 and [I-125]-BQ3020 binding to rat cerebellar endothelin receptors
    Widdowson, PS
    Kirk, CNP
    BRITISH JOURNAL OF PHARMACOLOGY, 1996, 118 (08) : 2126 - 2130
  • [4] [125I]BQ3020, a novel endothelin agonist selective for the endothelinB receptor subtype
    Assal, AA
    Gessner, G
    Jarvis, MF
    BRAIN RESEARCH PROTOCOLS, 1997, 1 (01): : 23 - 26
  • [5] SPECIES-DIFFERENCES IN THE BINDING CHARACTERISTICS OF [I-125]-IRL-1620, A POTENT AGONIST SPECIFIC FOR ENDOTHELIN-B RECEPTORS
    NAMBI, P
    PULLEN, M
    SPIELMAN, W
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1994, 268 (01): : 202 - 207
  • [6] CHARACTERIZATION OF 2 NEW ETB SELECTIVE RADIOLIGANDS, [I-125] BQ3020 AND [I-125] [ALA1,3,11,15]ET-1 IN HUMAN HEART
    MOLENAAR, P
    KUC, RE
    DAVENPORT, AP
    BRITISH JOURNAL OF PHARMACOLOGY, 1992, 107 (03) : 637 - 639
  • [7] REGIONAL HEMODYNAMIC-RESPONSES TO THE ET(B)-RECEPTOR-SELECTIVE AGONIST, BQ3020, IN CONSCIOUS RATS
    GARDINER, SM
    KEMP, PA
    BENNETT, T
    DAVENPORT, AP
    BRITISH JOURNAL OF PHARMACOLOGY, 1993, 109 : P131 - P131
  • [8] A NOVEL LIGAND, [I-125] BQ-3020, REVEALS THE LOCALIZATION OF ENDOTHELIN-ET(B) RECEPTORS
    KOBAYASHI, M
    IHARA, M
    SATO, N
    SAEKI, T
    OZAKI, S
    IKEMOTO, F
    YANO, M
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1993, 235 (01) : 95 - 100
  • [9] SPECIES-DIFFERENCES IN [I-125] INTERLEUKIN-1 BINDING IN BRAIN, ENDOCRINE AND IMMUNE TISSUES
    TAKAO, T
    NEWTON, RC
    DESOUZA, EB
    BRAIN RESEARCH, 1993, 623 (01) : 172 - 176
  • [10] A SELECTIVE ENDOTHELIN ET(A) ANTAGONIST, BQ-123, INHIBITS I-125 ENDOTHELIN-1 (I-125-ET-1) BINDING TO HUMAN MENINGIOMAS AND ANTAGONIZES ET-1-INDUCED PROLIFERATION OF MENINGIOMA CELLS
    KITAGAWA, N
    TSUTSUMI, K
    NIWA, M
    YAMAGA, S
    ANDA, T
    KHALID, H
    HIMENO, A
    TANIYAMA, K
    SHIBATA, S
    CELLULAR AND MOLECULAR NEUROBIOLOGY, 1994, 14 (02) : 105 - 118